#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Microvillous inclusion disease Chondrosarcoma Leukaemia High-grade B-cell lymphoma Restless legs syndrome Inflammatory myofibroblastic tumour Anti-neutrophil cytoplasmic antibody positive vasculitis Growth hormone deficiency Deafness neurosensory Glioma Chondrodystrophy Systemic sclerosis pulmonary Metabolic disorder Nasopharyngeal cancer Kawasaki's disease More trials…

    Learn about Rare Diseases

    Alagille syndrome – Trials in Disease Mantle cell lymphoma Bronchopulmonary dysplasia – Diagnostics Small intestine leiomyosarcoma Kearns-Sayre syndrome – Trials in Disease Medulloblastoma recurrent – Treatment Hereditary angioedema – Trials in Disease Ewing’s sarcoma recurrent – Treatment Lymphangioma – Trials in Disease Gastrointestinal stromal tumour – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elritercept Tinzaparin Mifamurtide M-(18F)-Fluorobenzylguanidine Daxdilimab VG801-1 Vib1116 Domvanalimab Bempedoic Acid Artemisia Vulgaris (312) Epoetin Alfa Niraparib Tosilate Monohydrate Palmidrol PEGZILARGINASE Antithrombin Iii Human [89Zr]Bms-986279 Belzupacap Sarotalocan Betibeglogene Autotemcel Tretinoin Ciclosporin A More therapies…

    Learn about Your Condition

    Systemic scleroderma Upper limb fracture Impaired gastric emptying Infection Procedural pain Neoplasm Meniscus operation Androgenetic alopecia Vascular malformation Hyperparathyroidism secondary Immunodeficiency Anal squamous cell carcinoma Thrombocytopenia Narcolepsy Appendicitis perforated More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Myelodysplastic syndrome

  • Study of momelotinib in patients with VEXAS syndrome and myelodysplastic syndrome who are dependent on or do not respond to steroid treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • VEXAS syndrome
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Momelotinib Dihydrochloride Monohydrate
    France

  • Study of venetoclax, treosulfan and fludarabine before stem cell transplant in patients with acute myeloid leukemia and myelodysplastic syndrome

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Fludarabine Phosphate Ph. Eur.
    • Treosulfan
    • Venetoclax
    Germany

  • Study on Metformin for Preventing Leukemia in Patients with Clonal Cytopenia and Low-Risk Myelodysplastic Syndromes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Metformin Hydrochloride
    Denmark

  • Study Comparing Oral Azacitidine and Cedazuridine with Subcutaneous Azacitidine for Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic myelomonocytic leukaemia
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Cedazuridine
    • Azacitidine
    Czechia France Germany Hungary Italy Poland +1

  • Study on the Safety and Effects of Inobrodib, Betamethasone Sodium Phosphate, and Dimethyl Fumarate in Patients with Advanced Blood and Bone Marrow Cancers

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Acute myeloid leukaemia
    • Plasma cell myeloma
    Investigated Drugs:
    • INOBRODIB
    • Teclistamab
    • Daratumumab
    Spain

  • Study on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Lisaftoclax
    • Azacitidine
    Belgium Bulgaria Czechia Finland France Germany +7
Previous Page
1 2 3 4 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!